胆汁酸通过抑制IL-17A表达及CCL20-CCR6介导的T细胞迁移改善银屑病样皮炎
本研究在IL-23微环DNA小鼠银屑病样皮炎模型中显示,口服次级胆汁酸(包括石胆酸、脱氧胆酸和3-氧代石胆酸)可显著改善皮炎且无明显肝毒性,其中石胆酸效力最强;静脉给予更低剂量石胆酸也有类似抗银屑病效果并显著抑制IL-17A反应。体外实验表明石胆酸减少IL-23刺激的小鼠T细胞产生IL-17A,且不依赖胆汁酸受体TGR5或FXR;胆汁酸还抑制角质形成细胞CCL20表达,减少CCR6表达Jurkat细胞迁移。
要点
- 口服次级胆汁酸可改善小鼠银屑病样皮炎且无明显肝毒性。
- 石胆酸在测试的胆汁酸中治疗银屑病样皮炎效力最强。
- 石胆酸静脉给药更低剂量即可抑制IL-17A并改善皮炎。
核心结论
- 胆汁酸通过直接抑制IL-17A产生和阻断CCL20介导的T细胞迁移来改善银屑病样皮炎,毒性极小,支持胆汁酸在银屑病中的潜在应用。
研究设计与样本
- 研究采用IL-23微环DNA小鼠银屑病样皮炎模型,并进行了体外实验。
主要发现
- 口服次级胆汁酸(包括石胆酸、脱氧胆酸和3-氧代石胆酸)显著改善银屑病样皮炎,且未诱导明显肝毒性;石胆酸效力最强。
- 静脉给予石胆酸剂量远低于口服,抗银屑病效果相当,并显著抑制IL-17A反应。
- 体外实验显示,在缺乏胆汁酸受体TGR5或FXR时,石胆酸减少IL-23刺激的小鼠T细胞产生IL-17A。
- 胆汁酸抑制角质形成细胞CCL20表达,减少在刺激角质形成细胞条件培养基中培养的CCR6表达Jurkat细胞的迁移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bile acids (BAs), produced in the liver and further transformed in the gut, are cholesterol-derived molecules involved in essential physiological processes. Recent studies suggest that BAs regulate T helper 17 cell function, but the underlying mechanism of this action and their therapeutic value in disease models remains unclear. Using an IL-23 minicircle DNA-based murine model of psoriasiform dermatitis, we showed that oral administration of secondary BAs, including lithocholic acid (LCA), deoxycholic acid, and 3-oxoLCA, significantly improved psoriasiform dermatitis without inducing apparent hepatotoxicity. Of the BAs tested, LCA possessed the greatest potency in treating psoriasiform dermatitis. Intravenous administration of LCA at a much lower dosage (compared with oral treatment) showed a comparable antipsoriatic effect and markedly suppressed the IL-17A response. Ex vivo experiments revealed that LCA reduced IL-17A production in IL-23-stimulated murine T cells in the absence of BA receptors TGR5 or FXR. Strikingly, BAs inhibited CCL20 expression in keratinocytes, which led to reduced migration of CCR6-expressing Jurkat cells cultured in the conditioned medium of stimulated keratinocytes. Thus, BAs improve psoriasiform dermatitis with minimal toxicity via direct inhibition of IL-17A production and blockade of CCL20-mediated trafficking, supporting the potential use of BAs in psoriasis.
引用
- Shi Z, Wu X, Wu CY, et al. Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6-Mediated Trafficking of T Cells. J Invest Dermatol. 2021. PMID: 34808237. doi:10.1016/j.jid.2021.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。